These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 34818177)
21. [Management of atrial fibrillation comorbid with coronary heart disease]. Takatsuki S Nihon Rinsho; 2013 Jan; 71(1):142-7. PubMed ID: 23631186 [TBL] [Abstract][Full Text] [Related]
22. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries. Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Schnabel RB; Cemin R; Kirchhof P; De Caterina R Int J Cardiol; 2018 Nov; 270():160-166. PubMed ID: 30220376 [TBL] [Abstract][Full Text] [Related]
23. Safety of direct oral anticoagulant - and antiplatelet therapy in patients with atrial fibrillation treated by carotid artery stenting. Nii K; Takemura Y; Inoue R; Morinaga Y; Mitsutake T; Higashi T J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104899. PubMed ID: 32402723 [TBL] [Abstract][Full Text] [Related]
24. Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation. McCarty D; Robinson A Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):37-49. PubMed ID: 26378211 [TBL] [Abstract][Full Text] [Related]
25. Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry". Fischer Q; Georges JL; Le Feuvre C; Sharma A; Hammoudi N; Berman E; Cohen S; Jolivet I; Silvain J; Helft G Int J Cardiol; 2018 Aug; 264():64-69. PubMed ID: 29776575 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of oral direct factor Xa inhibitors versus warfarin in patients with atrial fibrillation: a meta-analysis of randomized controlled trials. Xiang CL; Gong YZ; Zeng LJ; Wang R; Kea S; Chaudhary N; Tu RH; He Y Acta Cardiol; 2016 Jun; 71(3):349-57. PubMed ID: 27594130 [No Abstract] [Full Text] [Related]
27. New oral anticoagulants for nonvalvular atrial fibrillation with stable coronary artery disease: A meta-analysis. Cen Z; Meng Q; Cui K Pacing Clin Electrophysiol; 2020 Nov; 43(11):1393-1400. PubMed ID: 32975310 [TBL] [Abstract][Full Text] [Related]
28. Meta-Analysis of Antithrombotic Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention. Khan SU; Khan MU; Ghani AR; Lone AN; Arshad A; Kaluski E Am J Cardiol; 2018 May; 121(10):1200-1206. PubMed ID: 29548674 [TBL] [Abstract][Full Text] [Related]
29. Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention. Kerneis M; Yee MK; Mehran R; Nafee T; Bode C; Halperin JL; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Fox KAA; Gibson CM Circ Cardiovasc Interv; 2019 Feb; 12(2):e007124. PubMed ID: 30704287 [TBL] [Abstract][Full Text] [Related]
30. Antithrombotics in atrial fibrillation and coronary disease. Velagapudi P; Turagam MK; Agrawal H; Mittal M; Kocheril AG; Aggarwal K Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):977-86. PubMed ID: 25046150 [TBL] [Abstract][Full Text] [Related]
32. The role of rivaroxaban in atrial fibrillation and acute coronary syndromes. Reddy P; Giugliano RP J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):526-32. PubMed ID: 24659084 [TBL] [Abstract][Full Text] [Related]
33. Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. Yasuda S; Kaikita K; Akao M; Ako J; Matoba T; Nakamura M; Miyauchi K; Hagiwara N; Kimura K; Hirayama A; Matsui K; Ogawa H; N Engl J Med; 2019 Sep; 381(12):1103-1113. PubMed ID: 31475793 [TBL] [Abstract][Full Text] [Related]
34. Coronary artery disease in outpatients with nonvalvular atrial fibrillation: results from the multicenter RAMSES study. Dogan V; Başaran Ö; Beton O; Tekinalp M; Bolat I; Kalaycioğlu E; Aykan AÇ; Taşar O; Şafak Ö; Kalçik M; Yaman M; Kirma C; Biteker M Coron Artery Dis; 2016 Sep; 27(6):497-503. PubMed ID: 27182772 [TBL] [Abstract][Full Text] [Related]
35. Safety and effectiveness of oral factor Xa inhibitors versus warfarin in nonvalvular atrial fibrillation patients at high-risk for falls. Miao B; Alberts MJ; Bunz TJ; Coleman CI J Thromb Thrombolysis; 2019 Oct; 48(3):366-372. PubMed ID: 31228038 [TBL] [Abstract][Full Text] [Related]
36. Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5). Verheugt FWA; Ten Berg JM; Storey RF; Cuisset T; Granger CB J Am Coll Cardiol; 2019 Aug; 74(5):699-711. PubMed ID: 31277840 [TBL] [Abstract][Full Text] [Related]
37. Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a "less is more" concept regimen. Kawakami S; Yasuda S; Ogawa H J Cardiol; 2020 Jul; 76(1):35-43. PubMed ID: 32389534 [TBL] [Abstract][Full Text] [Related]
38. Effect of aspirin in addition to oral anticoagulants in stable coronary artery disease outpatients with an indication for anticoagulation. Schurtz G; Bauters C; Ducrocq G; Lamblin N; Lemesle G Panminerva Med; 2016 Dec; 58(4):271-285. PubMed ID: 27364228 [TBL] [Abstract][Full Text] [Related]
39. Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation. Fox KAA; Velentgas P; Camm AJ; Bassand JP; Fitzmaurice DA; Gersh BJ; Goldhaber SZ; Goto S; Haas S; Misselwitz F; Pieper KS; Turpie AGG; Verheugt FWA; Dabrowski E; Luo K; Gibbs L; Kakkar AK; JAMA Netw Open; 2020 Feb; 3(2):e200107. PubMed ID: 32101311 [TBL] [Abstract][Full Text] [Related]
40. Benefit of dual antithrombotic therapy with direct oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention: a systematic review and metaanalysis of randomized clinical trials. Zoppellaro G; Marchese GM; Squizzato A; Denas G; Patti G; De Caterina R; Pengo V Intern Emerg Med; 2020 Sep; 15(6):1093-1104. PubMed ID: 32617904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]